Hasil Pencarian - Katherine Buzzard

  • Menampilkan 1 - 16 hasil dari 16
Perbaiki Hasil
  1. 1
    Innate Immunity in the Central Nervous System: A Missing Piece of the Autoimmune Encephalitis Puzzle?

    Innate Immunity in the Central Nervous System: A Missing Piece of the Autoimmune Encephalitis Puzzle? oleh Robb Wesselingh, Robb Wesselingh, Helmut Butzkueven, Helmut Butzkueven, Katherine Buzzard, Katherine Buzzard, David Tarlinton, Terence J. O'Brien, Terence J. O'Brien, Terence J. O'Brien, Mastura Monif, Mastura Monif, Mastura Monif

    Diterbitkan 2019-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Prognosis in autoimmune encephalitis: Database

    Prognosis in autoimmune encephalitis: Database oleh James Broadley, Udaya Seneviratne, Paul Beech, Katherine Buzzard, Helmut Butzkueven, Terence O’Brien, Mastura Monif

    Diterbitkan 2018-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    3222 Does location matter? An exploration of autoimmune encephalitis in the rural and regional setting

    3222 Does location matter? An exploration of autoimmune encephalitis in the rural and regional setting oleh Helmut Butzkueven, Mastura Monif, Udaya Seneviratne, Robb Wesselingh, James Broadley, Katherine Buzzard, Cassie Nesbitt, Terence O'Brien, Nabil Seery

    Diterbitkan 2024-08-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    3218 Biomarkers of neurodegeneration as diagnostic and prognostic markers in autoimmune encephalitis

    3218 Biomarkers of neurodegeneration as diagnostic and prognostic markers in autoimmune encephalitis oleh Helmut Butzkueven, Mastura Monif, Terence J O'Brien, Robb Wesselingh, James Broadley, Katherine Buzzard, Nabil Seery, Sarah P Griffith

    Diterbitkan 2024-08-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    010 Real-world experience with ocrelizumab in the MSBase registry – Australian RRMS cohort

    010 Real-world experience with ocrelizumab in the MSBase registry – Australian RRMS cohort oleh Mark Slee, Suzanne Hodgkinson, Ernest Butler, Tim Spelman, Helmut Butzkueven, Jeanette Lechner-Scott, Richard Macdonell, Anneke Van Der Walt, Katherine Buzzard, MSBase Study Group, Bruno Marcel

    Diterbitkan 2021-08-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    3 Managing disease activity during treatment with natalizumab in relapsing-remitting multiple sclerosis

    3 Managing disease activity during treatment with natalizumab in relapsing-remitting multiple sclerosis oleh Nevin John, Nathaniel Lizak, Tomas Kalincik, Mark Slee, Suzanne Hodgkinson, Helmut Butzkueven, Jeanette Lechner-Scott, Anneke Van Der Walt, Izanne Roos, Katherine Buzzard, Olga Skibina, Sifat Sharmin

    Diterbitkan 2024-08-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    3138 Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis

    3138 Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis oleh Nevin John, Tomas Kalincik, Jeannette Lechner-Scott, Suzanne Hodgkinson, Helmut Butzkueven, Michael Barnett, Anneke Van Der Walt, Izanne Roos, Charles Malpas, Katherine Buzzard, Olga Skibina, Sifat Sharmin

    Diterbitkan 2024-08-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    072 Impact of telehealth on multiple sclerosis (MS) outpatient clinics during the COVID-19 pandemic

    072 Impact of telehealth on multiple sclerosis (MS) outpatient clinics during the COVID-19 pandemic oleh Trevor Kilpatrick, Vivien Li, Mastura Monif, Lisa Taylor, Nicola Taylor, Izanne Roos, Charles Malpas, Katherine Buzzard, Mark Marriott, Ai-Lan Nguyen, Chris Dwyer, Stefanie Roberts, Elizabeth Carle, Kelsey Tunnell

    Diterbitkan 2021-08-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Peripheral Immune Cell Ratios and Clinical Outcomes in Seropositive Autoimmune Encephalitis: A Study by the Australian Autoimmune Encephalitis Consortium

    Peripheral Immune Cell Ratios and Clinical Outcomes in Seropositive Autoimmune Encephalitis: A Study by the Australian Autoimmune Encephalitis Consortium oleh James Broadley, James Broadley, Robb Wesselingh, Robb Wesselingh, Udaya Seneviratne, Udaya Seneviratne, Udaya Seneviratne, Chris Kyndt, Chris Kyndt, Paul Beech, Paul Beech, Katherine Buzzard, Katherine Buzzard, Cassie Nesbitt, Cassie Nesbitt, Wendyl D’Souza, Wendyl D’Souza, Amy Brodtmann, Amy Brodtmann, Tomas Kalincik, Tomas Kalincik, Helmut Butzkueven, Helmut Butzkueven, Terence J. O’Brien, Terence J. O’Brien, Mastura Monif, Mastura Monif, Mastura Monif, Mastura Monif, Australian Autoimmune Encephalitis Consortium

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Efficacy of Cladribine Tablets as a Treatment for People With Multiple Sclerosis: Protocol for the CLOBAS Study (Cladribine, a Multicenter, Long-term Efficacy and Biomarker Australian Study)

    Efficacy of Cladribine Tablets as a Treatment for People With Multiple Sclerosis: Protocol for the CLOBAS Study (Cladribine, a Multicenter, Long-term Efficacy and Biomarker Austral... oleh Vicki E Maltby, Rodney A Lea, Mastura Monif, Marzena J Fabis-Pedrini, Katherine Buzzard, Tomas Kalincik, Allan G Kermode, Bruce Taylor, Suzanne Hodgkinson, Pamela McCombe, Helmut Butzkueven, Michael Barnett, Jeannette Lechner-Scott

    Diterbitkan 2021-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    008 Disease reactivation after cessation of disease-modifying therapy in relapsing-remitting multiple sclerosis

    008 Disease reactivation after cessation of disease-modifying therapy in relapsing-remitting multiple sclerosis oleh Steve Vucic, Jeannette Lechner-Scott, Mark Slee, Suzanne Hodgkinson, Ernest Butler, Helmut Butzkueven, Michael Barnett, Richard Macdonell, Anneke Van Der Walt, Charles B Malpas, Pamela McCombe, Emmanuelle Leray, Sandra Vukusic, Izanne Roos, Katherine Buzzard, Olga Skibina

    Diterbitkan 2021-08-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    3116 Longitudinal trajectories of digital upper limb biomarkers for multiple sclerosis

    3116 Longitudinal trajectories of digital upper limb biomarkers for multiple sclerosis oleh Tomas Kalincik, Jeannette Lechner-Scott, Helmut Butzkueven, Trevor Kilpatrick, Robert Hyde, David Darby, Michael Barnett, Anneke Van Der Walt, Yi Chao Foong, Bruce Taylor, Katherine Buzzard, Daniel Merlo, Melissa Gresle, Chao Zhu, Johan van Beek, Pamela Dobay

    Diterbitkan 2024-08-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    3115 Longitudinal trajectories of digital cognitive biomarkers for multiple sclerosis

    3115 Longitudinal trajectories of digital cognitive biomarkers for multiple sclerosis oleh Tomas Kalincik, Jeannette Lechner-Scott, Helmut Butzkueven, Trevor Kilpatrick, Robert Hyde, David Darby, Michael Barnett, Anneke Van Der Walt, Yi Chao Foong, Bruce Taylor, Katherine Buzzard, Daniel Merlo, Melissa Gresle, Chao Zhu, Johan van Beek, Pamela Dobay

    Diterbitkan 2024-08-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    2 The clinical relevance of MOG antibody testing in cerebrospinal fluid versus serum

    2 The clinical relevance of MOG antibody testing in cerebrospinal fluid versus serum oleh David Brown, Nevin John, Jeanette Lechner-Scott, Allan Kermode, Irene Tan, Anthony Fok, Stephen Reddel, Nigel Wolfe, Katherine Buzzard, Marzena Fabis-Pedrini, Sudarshini Ramanathan, Christopher Kneebone, Con Yiannikas, Benjamin Trewin, Molly Reynolds, Magdalena Lerch, Snehal Shah, Russel C Dale, Fabienne Brillot

    Diterbitkan 2024-08-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    Long-term clinical outcomes in patients with multiple sclerosis who are initiating disease-modifying therapy with natalizumab compared with BRACETD first-line therapies

    Long-term clinical outcomes in patients with multiple sclerosis who are initiating disease-modifying therapy with natalizumab compared with BRACETD first-line therapies oleh Helmut Butzkueven, Tomas Kalincik, Francesco Patti, Mark Slee, Bianca Weinstock-Guttman, Katherine Buzzard, Olga Skibina, Raed Alroughani, Alexandre Prat, Marc Girard, Dana Horakova, Eva Kubala Havrdova, Anneke Van der Walt, Sara Eichau, Robert Hyde, Nolan Campbell, Karthik Bodhinathan, Tim Spelman

    Diterbitkan 2024-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    3018 A multi-centre longitudinal study analysing disease modifying therapy prescribing patterns during the COVID-19 pandemic

    3018 A multi-centre longitudinal study analysing disease modifying therapy prescribing patterns during the COVID-19 pandemic oleh Nevin John, Steve Vucic, Riadh Gouider, Tomas Kalincik, Guillermo Izquierdo, Alexandre Prat, Marc Girard, Pierre Duquette, Pierre Grammond, Serkan Ozakbas, Jeannette Lechner-Scott, Cavit Boz, Julie Prevost, Recai Turkoglu, Vincent Van Pesch, Cristina Ramo-Tello, Mark Slee, Raed Alroughani, Vahid Shaygannejad, Daniele Spitaleri, José Luis Sánchez-Menoyo, Suzanne Hodgkinson, Rana Karabudak, Tim Spelman, Helmut Butzkueven, Noriko Isobe, Paul G Sanfilippo, Michael Barnett, Orla Gray, Maria José Sá, Allan Kermode, Guy Laureys, Richard Macdonell, Anneke Van Der Walt, Ayse Altintas, Mario Habek, Pamela McCombe, Seyed Mohammad Baghbanian, Yi Chao Foong, Riki Matsumoto, Abdullah Al-Asmi, Bruce Taylor, Samia J Khoury, Todd Hardy, Katherine Buzzard, Marzena Fabis-Pedrini, Louise Rath, Olga Skibina, Jiwon Oh, William M Carroll, Katrin Gross-Paju, Jan Schepel, Sara Eichau, Elisabetta Cartechini, Aysun Soysal, Davide Maimone, Anoushka Lal, Masoud Etemadifar, Oliver Gerlach, Saloua Mrabet, Emanuele D'Amico, Yolanda Blanco, Matteo Foschi, Melissa Cambron, Andrea Surcinelli, David Levitz, Liesbeth Van Hijfte, Mehmet Fatih Yetkin, Simón Cárdenas-Robledo, Emmanuelle Lapointe, Abdorreza Naser Moghadasi, Gregor Brecl Jakob, Talal Al-Harbi

    Diterbitkan 2024-08-01
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: